Evaluation and Management of Nonculprit Lesions in STEMI

Troels Thim; Nina W. van der Hoeven; Carmine Musto; Robin Nijveldt; Matthias Götberg; Thomas Engstrøm; Pieter C. Smits; Keith G. Oldroyd; Anthony H. Gershlick; Javier Escaned; Sergio Bravo Baptista; Luis Raposo; Niels van Royen; Michael Maeng

doi:10.1016/j.jcin.2020.02.030

Evaluation and Management of Nonculprit Lesions in STEMI

Troels Thim, Nina W. van der Hoeven, Carmine Musto, Robin Nijveldt, Matthias Götberg, Thomas Engstrøm, Pieter C. Smits, Keith G. Oldroyd, Anthony H. Gershlick, Javier Escaned, Sergio Bravo Baptista, Luis Raposo, Niels van Royen, Michael Maeng

Cardiology

Research output: Contribution to journal › Review article › peer-review

Abstract

Nonculprit lesions are frequently observed in patients with ST-segment elevation myocardial infarction. Results from recent randomized clinical trials suggest that complete revascularization after ST-segment elevation myocardial infarction improves outcomes. In this state-of-the-art paper, the authors review these trials and consider how best to determine which nonculprit lesions require revascularization and when this should be performed.

Original language	English
Pages (from-to)	1145-1154
Number of pages	10
Journal	JACC: Cardiovascular Interventions
Volume	13
Issue number	10
DOIs	https://doi.org/10.1016/j.jcin.2020.02.030
Publication status	Published - 2020

Subject classification (UKÄ)

Cardiac and Cardiovascular Systems

Free keywords

CFR
FFR
iFR
nonculprit coronary lesions
STEMI

Access to Document

10.1016/j.jcin.2020.02.030

Cite this

@article{bb034fd6aa254adcb6b6d36c74ab31c5,

title = "Evaluation and Management of Nonculprit Lesions in STEMI",

abstract = "Nonculprit lesions are frequently observed in patients with ST-segment elevation myocardial infarction. Results from recent randomized clinical trials suggest that complete revascularization after ST-segment elevation myocardial infarction improves outcomes. In this state-of-the-art paper, the authors review these trials and consider how best to determine which nonculprit lesions require revascularization and when this should be performed.",

keywords = "CFR, FFR, iFR, nonculprit coronary lesions, STEMI",

author = "Troels Thim and {van der Hoeven}, {Nina W.} and Carmine Musto and Robin Nijveldt and Matthias G{\"o}tberg and Thomas Engstr{\o}m and Smits, {Pieter C.} and Oldroyd, {Keith G.} and Gershlick, {Anthony H.} and Javier Escaned and Baptista, {Sergio Bravo} and Luis Raposo and {van Royen}, Niels and Michael Maeng",

year = "2020",

doi = "10.1016/j.jcin.2020.02.030",

language = "English",

volume = "13",

pages = "1145--1154",

journal = "JACC: Cardiovascular Interventions",

issn = "1936-8798",

publisher = "Elsevier",

number = "10",

}

TY - JOUR

T1 - Evaluation and Management of Nonculprit Lesions in STEMI

AU - Thim, Troels

AU - van der Hoeven, Nina W.

AU - Musto, Carmine

AU - Nijveldt, Robin

AU - Götberg, Matthias

AU - Engstrøm, Thomas

AU - Smits, Pieter C.

AU - Oldroyd, Keith G.

AU - Gershlick, Anthony H.

AU - Escaned, Javier

AU - Baptista, Sergio Bravo

AU - Raposo, Luis

AU - van Royen, Niels

AU - Maeng, Michael

PY - 2020

Y1 - 2020

N2 - Nonculprit lesions are frequently observed in patients with ST-segment elevation myocardial infarction. Results from recent randomized clinical trials suggest that complete revascularization after ST-segment elevation myocardial infarction improves outcomes. In this state-of-the-art paper, the authors review these trials and consider how best to determine which nonculprit lesions require revascularization and when this should be performed.

AB - Nonculprit lesions are frequently observed in patients with ST-segment elevation myocardial infarction. Results from recent randomized clinical trials suggest that complete revascularization after ST-segment elevation myocardial infarction improves outcomes. In this state-of-the-art paper, the authors review these trials and consider how best to determine which nonculprit lesions require revascularization and when this should be performed.

KW - CFR

KW - FFR

KW - iFR

KW - nonculprit coronary lesions

KW - STEMI

U2 - 10.1016/j.jcin.2020.02.030

DO - 10.1016/j.jcin.2020.02.030

M3 - Review article

C2 - 32438985

AN - SCOPUS:85084345472

SN - 1936-8798

VL - 13

SP - 1145

EP - 1154

JO - JACC: Cardiovascular Interventions

JF - JACC: Cardiovascular Interventions

IS - 10

ER -

Evaluation and Management of Nonculprit Lesions in STEMI

Abstract

Subject classification (UKÄ)

Free keywords

Access to Document

Fingerprint

Cite this